论文信息 - External applicability of SGLT2 inhibitor cardiovascular outcome trials to patients with type 2 diabetes and cardiovascular disease - 字舞流文

External applicability of SGLT2 inhibitor cardiovascular outcome trials to patients with type 2 diabetes and cardiovascular disease

H. Nathoe | L. Kappelle | G. D. de Borst | F. Visseren | H. D. de Valk | J. Westerink | Lisanne C A Smidt | Wendela L. de Ranitz-Greven | W. L. de Ranitz-Greven | L. C. Smidt | G. J. Borst | W. L. Ranitz-Greven | H. W. Valk | the UCC-SMART Study Group